THE 2-MINUTE RULE FOR API IN PHARMACEUTICAL MANUFACTURING

“The present predicament has uncovered some structural weaknesses during the EU’s medicines source chain as well as a higher dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides reported. She encouraged that supply chain issues be tackled in an EU pharmaceutical technique expected being introduced by